Endocrine, metabolic & immune disorders drug targets最新文献

筛选
英文 中文
Diagnostic Role of Tomography in Addison's Disease due to Adrenal Tuberculosis: A Case Report. 断层扫描在肾上腺结核所致阿狄森病中的诊断作用:病例报告。
Endocrine, metabolic & immune disorders drug targets Pub Date : 2025-01-01 DOI: 10.2174/0118715303305534240709115115
Juan Eduardo Quiroz-Aldave, Maria Del Carmen Durand-Vásquez, Elman Rolando Gamarra-Osorio, Sara Elizabeth Zavaleta-Aldave, Alejandra Noemí Zavaleta-Aldave, Jorge Rodriguez-Reyna, Cyntia Mileini Quesquen-Garcia, Luis Alberto Concepcion-Urteaga, Samuel Pecho-Silva, Luis Alejandro Rodriguez-Hidalgo, Jose Paz-Ibarra, Marcio Jose Concepcion-Zavaleta
{"title":"Diagnostic Role of Tomography in Addison's Disease due to Adrenal Tuberculosis: A Case Report.","authors":"Juan Eduardo Quiroz-Aldave, Maria Del Carmen Durand-Vásquez, Elman Rolando Gamarra-Osorio, Sara Elizabeth Zavaleta-Aldave, Alejandra Noemí Zavaleta-Aldave, Jorge Rodriguez-Reyna, Cyntia Mileini Quesquen-Garcia, Luis Alberto Concepcion-Urteaga, Samuel Pecho-Silva, Luis Alejandro Rodriguez-Hidalgo, Jose Paz-Ibarra, Marcio Jose Concepcion-Zavaleta","doi":"10.2174/0118715303305534240709115115","DOIUrl":"10.2174/0118715303305534240709115115","url":null,"abstract":"<p><strong>Introduction: </strong>Adrenal tuberculosis remains the main cause of primary adrenal insufficiency (PAI) in tuberculosis (TB)-prevalent regions. This case report details the presentation of PAI due to adrenal TB, where the etiological diagnosis involves Abdominal Computed Tomography (CT).</p><p><strong>Case report: </strong>A 37-year-old Peruvian woman with a history of TB contact displayed symptoms of adrenal insufficiency. PAI diagnosis was established, and CT imaging unveiled bilateral adrenal enlargement with calcifications. Treatment with prednisone and anti-TB therapy led to symptomatic improvement. Unfortunately, she succumbed to pneumonia after ten months of follow-up.</p><p><strong>Discussion: </strong>Adrenal TB must be considered in endemic regions and in the presence of a TB history. CT serves as a valuable diagnostic tool, particularly in settings with limited resources, revealing adrenal enlargement and calcifications.</p><p><strong>Conclusion: </strong>In patients with PAI, epidemiological history of TB, and when a rapid biopsy is not feasible, CT proves to be a valuable diagnostic method.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"421-427"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141794481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Bibliometric Study from 1992 to 2023 on the Relationship between Biological Clock and Diabetes. 从 1992 年到 2023 年关于生物钟与糖尿病关系的文献计量学研究。
Endocrine, metabolic & immune disorders drug targets Pub Date : 2025-01-01 DOI: 10.2174/0118715303316643240724095907
Dayuan Zhong, Hui Cheng, Huanjie Li, Xiangbo Kong
{"title":"A Bibliometric Study from 1992 to 2023 on the Relationship between Biological Clock and Diabetes.","authors":"Dayuan Zhong, Hui Cheng, Huanjie Li, Xiangbo Kong","doi":"10.2174/0118715303316643240724095907","DOIUrl":"10.2174/0118715303316643240724095907","url":null,"abstract":"<p><strong>Aims: </strong>A bibliometric study was conducted to gain deeper insights into the current state of research on diabetes and the biological clock (BC).</p><p><strong>Methods: </strong>The study involved a comprehensive search for literature related to diabetes and BC published between 1992 and 2023 in the Web of Science database.</p><p><strong>Results: </strong>Ninety-five articles were published in 65 journals, with six of these journals not included in the Journal Citation Reports as of 2022. Among the remaining 59 journals, 10 had an impact factor (IF) greater than 10, and 21 had an IF greater than 5. Twenty-nine journals belonged to Quartile 1, while 16 journals were part of Quartile 2. The articles were contributed by researchers from 22 countries, with the Netherlands and the USA being the most prolific contributors. However, the total number of citations for articles from the USA was significantly higher than that of the Netherlands. The co-occurrence analysis of title and abstract keywords primarily focused on investigating the mechanisms of BC. Regarding author keywords and keyword-plus, the co-occurrence analysis centered around diabetes and BC. International collaboration was prominent among developed countries, with the Netherlands, the USA, and France being major participants. Institution- wise cooperation primarily occurred between two research institutions in the Netherlands. In total, the 95 articles received 5,157 citations, averaging 54.28 citations per article.</p><p><strong>Conclusion: </strong>To foster advancements in this area, more attention and international cooperation are necessary. Emphasizing collaborative efforts can drive the development of novel approaches to manage diabetes and regulate blood glucose levels effectively.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"377-385"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141989876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Updated Review Summarizing the Anticancer Potential of Naringenin. 总结柚皮苷抗癌潜力的最新综述
Endocrine, metabolic & immune disorders drug targets Pub Date : 2025-01-01 DOI: 10.2174/0118715303308238240705061522
Srishti Sharma, Anuja Mishra, Seema Ramniwas, Pratibha Pandey
{"title":"An Updated Review Summarizing the Anticancer Potential of Naringenin.","authors":"Srishti Sharma, Anuja Mishra, Seema Ramniwas, Pratibha Pandey","doi":"10.2174/0118715303308238240705061522","DOIUrl":"10.2174/0118715303308238240705061522","url":null,"abstract":"<p><p>One important phytochemical is naringenin, which belongs to the flavanone class of polyphenols. It is found in citrus fruits, such as grapefruits, but it can also be found in tomatoes, cherries, and other food-grade medicinal plants. Naringenin has a significant chemotherapeutic promise, as several investigations have conclusively shown. Therefore, the goal of this review is to synthesize the literature that has been done on naringenin as a possible anti-cancer agent and clarify the mechanisms of action that have been described in treatment plans for different kinds of cancer. In a variety of cancer cells, naringenin works by affecting several pathways associated with cell cycle arrest, anti-metastasis, apoptosis, anti-angiogenesis, and DNA repair. It has been shown to alter several molecular targets linked to the development of cancer, such as drug transporters, transcription factors, reactive nitrogen species, reactive oxygen species, cellular kinases, and inflammatory cytokines and regulators of the cell cycle. In summary, this research provides significant insights into the potential of naringenin as a strong and prospective candidate for use in medicines, nutraceuticals, functional foods, and dietary supplements to improve the management of carcinoma.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"364-376"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141617896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The "Magnificent Seven" in Oral and Systemic Health against COVID-19. 对抗 COVID-19 的口腔和全身健康 "七巨头"。
Endocrine, metabolic & immune disorders drug targets Pub Date : 2025-01-01 DOI: 10.2174/0118715303296892240506100532
Marina Di Domenico, Alessandro Motta, Tommaso Dai Pra, Stefania Cantore, Mario Dioguardi, Eugenia Rosalinda Zanella, Roberto Arrigoni, Danila De Vito, Filiberto Mastrangelo
{"title":"The \"Magnificent Seven\" in Oral and Systemic Health against COVID-19.","authors":"Marina Di Domenico, Alessandro Motta, Tommaso Dai Pra, Stefania Cantore, Mario Dioguardi, Eugenia Rosalinda Zanella, Roberto Arrigoni, Danila De Vito, Filiberto Mastrangelo","doi":"10.2174/0118715303296892240506100532","DOIUrl":"10.2174/0118715303296892240506100532","url":null,"abstract":"<p><p>The COVID-19 pandemic impacted all areas of daily life, including medical care. Unfortunately, to date, no specific treatments have been found for the cure of this disease, and therefore, it is advisable to implement all possible strategies to prevent infection. In this context, it is important to better define the role of all behaviors, in particular nutrition, in order to establish whether these can both prevent infection and improve the outcome of the disease in patients with COVID-19. There is sufficient evidence to demonstrate that immune response can be weakened by inadequate nutrition. Nutrition management and treatment are very important to enhance the immune response of an infected person against RNA viral infection. A complete nutritional assessment should include anthropometric, dietary, and laboratorial assessment, as well as a multidisciplinary discussion about the patient's clinical condition. In this way, it is possible to establish an individualized nutritional approach to contribute to improving clinical and nutritional prognoses. From this point of view, diet, through intake of vitamins and trace elements and maintaining adequate functioning of the intestinal barrier, can reduce the severity of the COVID-19 infection. In this study, we provide an overview of the effects of diet on COVID-19 infection in non-cancer patients. This notion needs to be further evaluated, and thus, identification, characterization, and targeting of the right nutrition principles related to the management of patients with COVID-19 are likely to improve outcomes and may prevent the infection or lead to a cure.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"271-280"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141156113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Essential Role of Traditional Chinese Medicine Compounds in Regulating Recurrent Spontaneous Abortion by Inhibiting Oxidative Stress. 中药复方在抑制氧化应激调节复发性自然流产中的重要作用
Endocrine, metabolic & immune disorders drug targets Pub Date : 2025-01-01 DOI: 10.2174/0118715303302424240724070133
Yi Jin, Huimin Dang, Meihe Li
{"title":"The Essential Role of Traditional Chinese Medicine Compounds in Regulating Recurrent Spontaneous Abortion by Inhibiting Oxidative Stress.","authors":"Yi Jin, Huimin Dang, Meihe Li","doi":"10.2174/0118715303302424240724070133","DOIUrl":"10.2174/0118715303302424240724070133","url":null,"abstract":"<p><p>Due to the lack of accurate registration of RSA and miscarriages, many early miscarriages are overlooked and not diagnosed or treated promptly in hospitals. This uncertainty in pathogenesis prevents clinicians from taking targeted therapeutic measures, leading to unsatisfactory treatment outcomes and placing a heavy burden on the patient's family and the healthcare system. Oxidative stress is present in embryonic development and affects the regulation of oxidative stress in pregnancy and the reproductive endocrine system. Oxidative stress injury is a significant pathogenesis of RSA, so improving the body's ability to resist oxidative stress injury is crucial in treating RSA. For patients with RSA, there is an urgent need for safe, efficient, and cost-effective anti-oxidative stress drugs, and there is growing evidence that treatment with Traditional Chinese medicine (TCM) can improve pregnancy success with fewer adverse effects. Many active ingredients for treating RSA are mainly derived from certain components of TCM, including flavonoids, phenols, and other compounds, which have been shown to treat RSA directly or indirectly by targeting anti-oxidative stress-related pathways. This article summarizes the experimental and clinical evidence of several common TCM compounds for treating RSA. It provides ideas and perspectives for further exploring the pathogenesis of RSA and TCM compounds for treating RSA.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"353-363"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obesity in Prediabetic Patients: Management of Metabolic Complications and Strategies for Prevention of Overt Diabetes. 糖尿病前期患者的肥胖症:新陈代谢并发症的管理和预防显性糖尿病的策略。
Endocrine, metabolic & immune disorders drug targets Pub Date : 2025-01-01 DOI: 10.2174/0118715303282327240507184902
Marco Chianelli, Marina Armellini, Maria Carpentieri, Carmela Coccaro, Carla Micaela Cuttica, Alessandra Fusco, Simonetta Marucci, Anna Nelva, Maurizio Nizzoli, Maria Chantal Ponziani, Marcello Sciaraffia, Francesco Tassone, Luca Busetto
{"title":"Obesity in Prediabetic Patients: Management of Metabolic Complications and Strategies for Prevention of Overt Diabetes.","authors":"Marco Chianelli, Marina Armellini, Maria Carpentieri, Carmela Coccaro, Carla Micaela Cuttica, Alessandra Fusco, Simonetta Marucci, Anna Nelva, Maurizio Nizzoli, Maria Chantal Ponziani, Marcello Sciaraffia, Francesco Tassone, Luca Busetto","doi":"10.2174/0118715303282327240507184902","DOIUrl":"10.2174/0118715303282327240507184902","url":null,"abstract":"<p><p>Obesity and prediabetes affect a substantial part of the general population, but are largely underdiagnosed, underestimated, and undertreated. Prediabetes differs from diabetes only in the degree of hyperglycaemia consequent to the progressive decline in residual beta-cell function. Both prediabetes and diabetes occur as a consequence of insulin resistance that starts several years before the clinical onset of overt diabetes. Macrovascular complications in patients with diabetes are mainly caused by insulin resistance. This is why in prediabetes, the overall cardiovascular risk is, by all means, similar to that in patients with diabetes. It is important, therefore, to identify prediabetes and treat patients not only to prevent or delay the onset of diabetes, but to reduce the cardiovascular risk associated with prediabetes. This review provides an overview of the pathophysiology of prediabetes in patients with obesity and the progression toward overt diabetes. We have reviewed nutritional and pharmacological approaches to the management of obesity and reduced glucose tolerance, and the treatment of the major comorbidities in these patients, including hypertension, dyslipidaemia, and Metabolic dysfunction-associated Steatotic Liver Disease (MASLD), has also been reviewed. In patients with obesity and prediabetes, the nutritional approach is similar to that adopted for patients with obesity and diabetes; treatments of dyslipidaemia and hypertension also have the same targets compared to patients with diabetes. MASLD is a critical issue in these patients; in the prediabetic state, MASLD rarely progresses into fibrosis. This highlights the importance of the early recognition of this pathological condition before patients become diabetic when the risk of fibrosis is much higher. It is necessary to raise awareness of the clinical relevance of this pathological condition in order to prompt early intervention before complications occur. The single most important therapeutic goal is weight loss, which must be early and persistent.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"8-36"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141082185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Androgen Signaling in Prostate Cancer: When a Friend Turns Foe. 前列腺癌中的雄激素信号转导:当朋友变成敌人
Endocrine, metabolic & immune disorders drug targets Pub Date : 2025-01-01 DOI: 10.2174/0118715303313528240523101940
Swaroop Kumar Pandey, Usha Sabharwal, Swati Tripathi, Anuja Mishra, Neha Yadav, Hemlata Dwivedi-Agnihotri
{"title":"Androgen Signaling in Prostate Cancer: When a Friend Turns Foe.","authors":"Swaroop Kumar Pandey, Usha Sabharwal, Swati Tripathi, Anuja Mishra, Neha Yadav, Hemlata Dwivedi-Agnihotri","doi":"10.2174/0118715303313528240523101940","DOIUrl":"10.2174/0118715303313528240523101940","url":null,"abstract":"<p><p>Androgen (AR) signaling is the main signaling for the development of the prostate and its normal functioning. AR is highly specific for testosterone and dihydrotestosterone, significantly contributing to prostate development, physiology, and cancer. All these receptors have emerged as crucial therapeutic targets for PCa. In the year 1966, the Noble prize was awarded to Huggins and Hodge for their groundbreaking discovery of AR. As it is a pioneer transcription factor, it belongs to the steroid hormone receptor family and consists of domains, including DNA binding domain (DBD), hormone response elements (HRE), C-terminal ligand binding domain (LBD), and N-terminal regulatory domains. Structural variations in AR, such as AR gene amplification, LBD mutations, alternative splicing of exons, hypermethylation of AR, and co- regulators, are major contributors to PCa. It's signaling is crucial for the development and functioning of the prostate gland, with the AR being the key player. The specificity of AR for testosterone and dihydrotestosterone is important in prostate physiology. However, when it is dysregulated, AR contributes significantly to PCa. However, the structural variations in AR, such as gene amplification, mutations, alternative splicing, and epigenetic modifications, drive the PCa progression. Therefore, understanding AR function and dysregulation is essential for developing effective therapeutic strategies. Thus, the aim of this review was to examine how AR was initially pivotal for prostate development and how it turned out to show both positive and detrimental implications for the prostate.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"37-56"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insulin Abuse: A Case Report of Munchausen Syndrome. 胰岛素滥用:孟乔森综合症病例报告。
Endocrine, metabolic & immune disorders drug targets Pub Date : 2025-01-01 DOI: 10.2174/0118715303284965240603103906
Elif Basaran, Nihal Tastekin, Yunus Emre Aytekin, Gulali Aktas
{"title":"Insulin Abuse: A Case Report of Munchausen Syndrome.","authors":"Elif Basaran, Nihal Tastekin, Yunus Emre Aytekin, Gulali Aktas","doi":"10.2174/0118715303284965240603103906","DOIUrl":"10.2174/0118715303284965240603103906","url":null,"abstract":"<p><p>Hypoglycaemia in individuals with diabetes is defined as the presence of signs or symptoms in addition to potentially occurring abnormal plasma glucose levels in the patient. Munchausen Syndrome (MS) is characterized by the deliberate induction of physical or psychological symptoms or the act of pretending to have symptoms. Patient reports of this factitious disease pattern are limited in the literature. The diagnosis and treatment of this syndrome, which is among factitious disorders, is very difficult. Endocrinological complaints are very common among those admitted to the hospitals.</p><p><strong>Background: </strong>Unnecessary and numerous examinations cause financial losses and loss of time for both the individual and the healthcare system. In this case report, we aimed to discuss the management of a patient who tried to gain secondary gain by creating artificial hypoglycemia attacks.</p><p><strong>Case report: </strong>In this case report, the diagnosis of Munchausen syndrome given to a 28-year-old female patient who was diagnosed with type I diabetes and repeatedly admitted to the hospital due to hypoglycemia attacks is discussed.</p><p><strong>Conclusion: </strong>Munchausen syndrome is an important and often overlooked diagnosis that should be kept in mind due to the possibility of individuals harming themselves unpredictably, as well as causing disruptions in the healthcare system and wasting time due to numerous and unnecessary examinations and evaluations. For this reason, it is a diagnosis that should be kept in mind in cases of unexplained hypoglycemia attacks.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"340-343"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Glimpse of Research Trends and Frontiers in the Etiology of Premature Ovarian Insufficiency via Bibliometric Analysis. 通过文献计量分析一窥卵巢早衰病因学的研究趋势和前沿。
Endocrine, metabolic & immune disorders drug targets Pub Date : 2025-01-01 DOI: 10.2174/0118715303313887240624071238
Duan Li, Yingxue Liu, Yameng Hui, Bing Li, Cuifang Hao
{"title":"A Glimpse of Research Trends and Frontiers in the Etiology of Premature Ovarian Insufficiency <i>via</i> Bibliometric Analysis.","authors":"Duan Li, Yingxue Liu, Yameng Hui, Bing Li, Cuifang Hao","doi":"10.2174/0118715303313887240624071238","DOIUrl":"10.2174/0118715303313887240624071238","url":null,"abstract":"<p><strong>Introduction: </strong>Premature Ovarian Insufficiency (POI) is the most common reproductive aging disorder in women of reproductive age, which is characterized by decreased ovarian function in women before the age of 40. Etiology research of POI has garnered interest and attention from scholars worldwide over the past decades.</p><p><strong>Methods: </strong>However, to the best of our knowledge, no comprehensive survey with bibliometric analysis has been conducted yet on the research trends of POI etiology. This article aimed to analyze current scientific findings on the etiology of POI, offering innovative ideas for further research. Research articles on the etiology of POI from 1994 to 2023 were collected from the Web of Science Core Collection. A total of 456 research articles were included, and the total number of publications increased annually. We used VOSviewer and bibliometric.com to analyze the keywords, terms, institution, publication country/region, author name, publication journal, and the sum of times the articles have been cited.</p><p><strong>Results: </strong>This study has shown that a research hotspot is the genetic etiology of POI; however, there is still a lack of research on the impact of epigenetic alterations, iatrogenic injuries, environmental pollution, social stress, and unhealthy lifestyles on the pathogenesis of POI.</p><p><strong>Conclusion: </strong>The factors illustrated here represent potential future directions for POI etiology research and warrant more attention from researchers.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"310-325"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioengineered Cell Therapies for Endocrine Dysfunction: Advancements and Clinical Prospects. 治疗内分泌功能障碍的生物工程细胞疗法:进展与临床前景》。
Endocrine, metabolic & immune disorders drug targets Pub Date : 2025-01-01 DOI: 10.2174/0118715303311209240709115156
Dilpreet Singh
{"title":"Bioengineered Cell Therapies for Endocrine Dysfunction: Advancements and Clinical Prospects.","authors":"Dilpreet Singh","doi":"10.2174/0118715303311209240709115156","DOIUrl":"10.2174/0118715303311209240709115156","url":null,"abstract":"","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"349-352"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141794478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信